<DOC>
	<DOCNO>NCT02093000</DOCNO>
	<brief_summary>This prospective , open-label , single arm , non-interventional study investigate effectiveness Avastin monotherapy patient lung adenocarcinoma previously receive 4 6 cycle induction platinum doublet plus Avastin . The study expect last approximately 28 month .</brief_summary>
	<brief_title>A Study Examining Maintenance Avastin Monotherapy Patients With Advanced Lung Adenocarcinoma</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>18 year old Patients previously receive 4 6 cycle induction platinum doublet plus bevacizumab Patients receive 1 cycle bevacizumab maintenance treatment meet summary product characteristic guideline Patients receive first cycle maintenance bevacizumab 4 week postinduction tumor assessment Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>